CIK 0001971387 · <br>Emerging growth company
Liminatus Pharma, Inc.
Sign in to watch- Ticker
- LIMN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 213-273-5453
- Business address
- 12611 HIDDENCREEK WAY, UNIT C, CERRITOS, CA, 90703
- Former names
- Iris Parent Holding Corp.
Securities
- LIMN Class A Common Stock Nasdaq
- LIMNW Warrants Nasdaq
- 8-K Event Delisting notice
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Delisting notice
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
Page 2 of 6 · 109 filings